Wellcome

Advances in Pharma Business Management and Research (Record no. 552181)

MARC details
000 -LEADER
fixed length control field 04557nam a22006375i 4500
001 -
control field 978-3-030-35918-8
003 -
control field DE-He213
005 -
control field 20211012180217.0
007 -
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200219s2020 sz | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783030359188
-- 978-3-030-35918-8
024 7# -
-- 10.1007/978-3-030-35918-8
-- doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
-- RS380
-- RS190-210
072 #7 -
-- TDCW
-- bicssc
-- MED072000
-- bisacsh
-- TDC
-- thema
082 04 -
Classification number 615.19
-- 23
245 10 - TITLE STATEMENT
Title Advances in Pharma Business Management and Research
Remainder of title Volume 1 /
Statement of responsibility, etc edited by Lars Schweizer, Theodor Dingermann, Otto Quintus Russe, Christian Jansen.
250 ## - EDITION STATEMENT
Edition statement 1st ed. 2020.
300 ## - PHYSICAL DESCRIPTION
Extent X, 85 p. 11 illus.
Other physical details online resource.
505 0# -
Formatted contents note Chapter 1. Introduction: Trends and developments in the pharmaceutical and life sciences industry -- Chapter 2. Relevance of instruments for measurements of Quality of Life in the AMNOG Context -- Chapter 3. The quality management system for R&D project and portfolio management in a pharmaceutical company -- Chapter 4. Brexit and Its Impact on Pharmaceutical Law - Implications for global pharma companies -- Chapter 5. Implementation of Measurable and Sustainable Actions to Improve Employee's Engagement and Business Performance - Global Medical Clinical & Regulatory Affairs (GMCRA) - A Role Model at Fresenius Kabi -- Chapter 6. Leadership Models and Work Behavior: An Empirical Analysis of Consequences of Authentic and Transformational Leadership -- Chapter 7. Alliance Management at Merck - Establishing an operational 100-day plan for alliance launches and management.
650 #0 -
Topical term or geographic name as entry element Pharmaceutical technology.
Topical term or geographic name as entry element Health care management.
Topical term or geographic name as entry element Health services administration.
Topical term or geographic name as entry element Medical laws and legislation.
Topical term or geographic name as entry element Pharmacy.
Topical term or geographic name as entry element Pharmacy management.
Topical term or geographic name as entry element Pharmaceutical Sciences/Technology.
Topical term or geographic name as entry element Health Care Management.
Topical term or geographic name as entry element Medical Law.
Topical term or geographic name as entry element Pharmacy.
Topical term or geographic name as entry element Pharmacoeconomics and Health Outcomes.
700 1# -
Personal name Schweizer, Lars.
Relator term editor.
Personal name Dingermann, Theodor.
Relator term editor.
Personal name Russe, Otto Quintus.
Relator term editor.
Personal name Jansen, Christian.
Relator term editor.
710 2# -
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
856 40 -
Uniform Resource Identifier https://doi.org/10.1007/978-3-030-35918-8
245 10 - TITLE STATEMENT
-- [electronic resource] :
264 #1 -
-- Cham :
-- Springer International Publishing :
-- Imprint: Springer,
-- 2020.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
347 ## -
-- text file
-- PDF
-- rda
506 0# -
-- Open Access
520 ## -
-- This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master's theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business.
-- https://scigraph.springernature.com/ontologies/product-market-codes/B21010
-- https://scigraph.springernature.com/ontologies/product-market-codes/527030
-- https://scigraph.springernature.com/ontologies/product-market-codes/R16005
-- https://scigraph.springernature.com/ontologies/product-market-codes/F00008
-- https://scigraph.springernature.com/ontologies/product-market-codes/H69020
700 1# -
-- edt
-- http://id.loc.gov/vocabulary/relators/edt
-- edt
-- http://id.loc.gov/vocabulary/relators/edt
-- edt
-- http://id.loc.gov/vocabulary/relators/edt
-- edt
-- http://id.loc.gov/vocabulary/relators/edt
773 0# -
-- Springer Nature eBook
776 08 -
-- Printed edition:
-- 9783030359171
-- Printed edition:
-- 9783030359195
-- Printed edition:
-- 9783030359201
912 ## -
-- ZDB-2-SBL
-- ZDB-2-SXB
-- ZDB-2-SOB
950 ## -
-- Biomedical and Life Sciences (SpringerNature-11642)
-- Biomedical and Life Sciences (R0) (SpringerNature-43708)

No items available.

No. of hits (from 9th Mar 12) :

Powered by Koha